Variant report
Variant | rs67844728 |
---|---|
Chromosome Location | chr17:66576490-66576491 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:66539200-66588000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
2 | chr17:66551800-66587800 | Weak transcription | H1 Cell Line | embryonic stem cell |
3 | chr17:66552000-66584200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr17:66552000-66585200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr17:66571200-66578000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr17:66572000-66578400 | Enhancers | NHDF-Ad | bronchial |
7 | chr17:66572200-66577600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
8 | chr17:66572200-66591800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr17:66572400-66577400 | Enhancers | Adipose Nuclei | Adipose |
10 | chr17:66572600-66581200 | Weak transcription | Gastric | stomach |
11 | chr17:66572800-66582800 | Weak transcription | Brain Angular Gyrus | brain |
12 | chr17:66573400-66577200 | Weak transcription | NHLF | lung |
13 | chr17:66573600-66578000 | Weak transcription | Right Atrium | heart |
14 | chr17:66573800-66578200 | Weak transcription | Placenta | Placenta |
15 | chr17:66574000-66576600 | Weak transcription | Placenta Amnion | Placenta Amnion |
16 | chr17:66575200-66576800 | Flanking Active TSS | Liver | Liver |
17 | chr17:66575200-66577200 | Enhancers | Fetal Thymus | thymus |
18 | chr17:66575200-66577400 | Enhancers | Primary monocytes fromperipheralblood | blood |
19 | chr17:66575400-66576800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
20 | chr17:66575400-66577000 | Enhancers | Esophagus | oesophagus |
21 | chr17:66575400-66577200 | Enhancers | Ovary | ovary |
22 | chr17:66575600-66577400 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
23 | chr17:66575800-66576600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
24 | chr17:66575800-66579400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
25 | chr17:66576000-66576600 | Flanking Active TSS | HepG2 | liver |
26 | chr17:66576000-66577200 | Enhancers | Colon Smooth Muscle | Colon |
27 | chr17:66576000-66577400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
28 | chr17:66576000-66577400 | Enhancers | Fetal Lung | lung |
29 | chr17:66576000-66578000 | Enhancers | Osteobl | bone |
30 | chr17:66576000-66578400 | Weak transcription | Pancreas | Pancrea |
31 | chr17:66576200-66576800 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
32 | chr17:66576200-66578000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
33 | chr17:66576200-66581800 | Weak transcription | Lung | lung |
34 | chr17:66576200-66581800 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
35 | chr17:66576400-66576800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
36 | chr17:66576400-66577000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
37 | chr17:66576400-66577000 | Bivalent Enhancer | Primary neutrophils fromperipheralblood | blood |
38 | chr17:66576400-66577000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
39 | chr17:66576400-66577400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
40 | chr17:66576400-66577400 | Enhancers | Spleen | Spleen |
41 | chr17:66576400-66581000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |